China Biotech Services Holdings Limited (HKG:8037)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.5900
-0.0100 (-1.67%)
Jun 1, 2026, 1:26 PM HKT
Market Cap585.44M +11.1%
Revenue (ttm)73.50M +4.2%
Net Income-68.78M
EPS-0.07
Shares Out 975.73M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,000
Open0.6000
Previous Close0.6000
Day's Range0.5900 - 0.6000
52-Week Range0.4800 - 1.3300
Beta-0.75
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About HKG:8037

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People’s Republic of China and Hong Kong. The company operates through Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Insurance Brokerage, BNCT, and Others segments. It also engages in the provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products; insurance brokerage services; provision of boron n... [Read more]

Sector Healthcare
Founded 1996
Employees 133
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8037
Full Company Profile

Financial Performance

In 2025, HKG:8037's revenue was 73.50 million, an increase of 4.25% compared to the previous year's 70.51 million. Losses were -68.78 million, -65.29% less than in 2024.

Financial Statements